Breaking News Instant updates and real-time market news.

2018-10-30 08:44:44 KO Coca-Cola $46.44 0.53 (1.15%) 08:44 10/30/18 10/30 08:44 10/30/18 08:44	Coca-Cola says sales boosted by bottled water, low-sugar drinks Says gaining share in a growing industry. Says currency headwinds were stronger than expected. Says top and bottom-line growth is broad-based. Says macroeconomic environment in Turkey, Middle East is "tough". Says natural disasters overshadowed pipeline in Japan. Says flood in Japan destroyed a bottling facility. Says Mexico continues to perform well. Says continues to deliver strong performance in North American marketplace. Says sales boosted by bottled water, low-sugar drinks. Says remains disciplined about allocation of capital and focus on M&A as an enabler. Says will aim to preserve Costa's unique capabilities. Says created Global Ventures group to get maximum value of acquisitions. Says believes leadership changes will set up company for success in years to come. Comments taken from Q3 earnings conference call.	30 Oct 03 Mar
KO Coca-Cola $46.44 0.53 (1.15%) 09/13/18 GUGG 09/13/18 INITIATION GUGG Buy Coca-Cola initiated with a Buy at Guggenheim 09/14/18 GUGG 09/14/18 INITIATION Target $51 GUGG Buy Coca-Cola initiated with a Buy on above consensus growth at Guggenheim Guggenheim analyst Laurent Grandet initiated Coca-Cola with a Buy and $51 price target and above consensus estimates saying the company is now focused on aggressively innovating across the non-alcoholic beverage space. Grandet sees growth driven by the company's global market leadership in the highly profitable carbonated soft drink segment, rapid and aggressive innovation combined with an acquisition strategy, dominance in on-premise, strength of global Coke bottling system, and an asset light operating model. 09/18/18 STFL 09/18/18 NO CHANGE Target $66 STFL Buy Monster Beverage likely to hike prices regardless of Red Bull, says Stifel Stifel analyst Mark Astrachan said he still anticipates Monster Beverage will increase prices on its U.S. legacy business, which represents about two-thirds of sales, by about 4% in the fourth quarter of 2018 and raise prices on its brands acquired from Coca-Cola (KO) in the first quarter of 2019 despite industry talks that indicate Red Bull does not currently plan to follow Monster's lead. While noting that he does not view Red Bull's reported lack of current pricing intent as definitive, Astrachan said that should it not follow that he anticipates no material impact to Monster's volume or share trends based on his analysis of the last price increase by both companies in 2015. He maintains a Buy rating and $66 price target on Monster shares. 10/03/18 RBCM 10/03/18 NO CHANGE Target $115 RBCM Sector Perform PepsiCo price target raised to $115 from $111 at RBC Capital RBC Capital analyst Nik Modi raised his price target on PepsiCo (PEP) to $115 after its Q3 results, saying the accelerated from the first half 5% organic growth was better than his expected 2.4% and marked an "encouraging beat". The analyst notes however that the "spike" in growth came at a cost of a 70bps operating margin contraction and keeps his Sector Perform rating, forecasting Coca-Cola (KO) to continue outgrowing PepsiCo because of its "better execution".

2018-10-30 08:44:44

Coca-Cola

$46.44: 0.53 (1.15%)

08:44

10/30/18

10/30

08:44

10/30/18

08:44

Coca-Cola says sales boosted by bottled water, low-sugar drinks

Says gaining share in a growing industry. Says currency headwinds were stronger than expected. Says top and bottom-line growth is broad-based. Says macroeconomic environment in Turkey, Middle East is "tough". Says natural disasters overshadowed pipeline in Japan. Says flood in Japan destroyed a bottling facility. Says Mexico continues to perform well. Says continues to deliver strong performance in North American marketplace. Says sales boosted by bottled water, low-sugar drinks. Says remains disciplined about allocation of capital and focus on M&A as an enabler. Says will aim to preserve Costa's unique capabilities. Says created Global Ventures group to get maximum value of acquisitions. Says believes leadership changes will set up company for success in years to come. Comments taken from Q3 earnings conference call.

30
Oct
03
Mar

KO Coca-Cola

$46.44: 0.53 (1.15%)

09/13/18: GUGG

09/14/18: GUGG

09/18/18: STFL

10/03/18: RBCM

TODAY'S FREE FLY STORIES

PLXP PLx Pharma $5.11 -0.11 (-2.11%) 07:27 02/19/19 02/19 07:27 02/19/19 07:27 Conference/Events	PLx Pharma to host special shareholder meeting » Special shareholder… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Feb
NBRV Nabriva Therapeutics $2.08 0.045 (2.22%) 07:27 02/19/19 02/19 07:27 02/19/19 07:27 Hot Stocks	Nabriva Therapeutics announces FDA acceptance of lefamulin NDAs » Nabriva Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	30 Apr
WORX SCWorx $5.74 -0.07 (-1.20%) 07:27 02/19/19 02/19 07:27 02/19/19 07:27 Hot Stocks	SCWorx announces new customer service agreement » SCWorx has expanded its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ARNC Arconic $17.56 0.07 (0.40%) , JPM JPMorgan $105.56 3.14 (3.07%) 07:25 02/19/19 02/19 07:25 02/19/19 07:25 Hot Stocks	Arconic announces $700M accelerated share repurchase agreement » Arconic (ARNC) announced… ARNC Arconic $17.56 0.07 (0.40%) JPM JPMorgan $105.56 3.14 (3.07%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	26 Feb
ICPT Intercept $110.77 -0.42 (-0.38%) 07:24 02/19/19 02/19 07:24 02/19/19 07:24 Hot Stocks	Intercept intends to file for OCA regulatory approval in U.S., Europe in 2H19 » "We are thrilled to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	18 May

CNMD Conmed $71.94 0.73 (1.03%) 07:24 02/19/19 02/19 07:24 02/19/19 07:24 Upgrade	Conmed rating change » Conmed reinstated with an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	06 Mar 18 May
ACB Aurora Cannabis $7.04 -0.05 (-0.71%) , TLRY Tilray $76.46 -0.2 (-0.26%) … 07:23 02/19/19 02/19 07:23 02/19/19 07:23 Recommendations	Aurora Cannabis, Tilray, CV Sciences, Cronos Group, General Cannabis, CannTrust Holdings, Aphria, MediPharm Labs, Canopy Growth, India Globalization Capital analyst commentary » Moody's price target… ACB Aurora Cannabis $7.04 -0.05 (-0.71%) TLRY Tilray $76.46 -0.2 (-0.26%) CVSI CV Sciences $0.00 (0.00%) CRON Cronos Group $21.28 0.46 (2.21%) CANN General Cannabis $0.00 (0.00%) CNTTF CannTrust Holdings $0.00 (0.00%) APHA Aphria $9.58 0.49 (5.39%) MLCPF MediPharm Labs $0.00 (0.00%) CGC Canopy Growth $47.54 1.49 (3.24%) IGC India Globalization Capital $0.00 (0.00%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Feb 21 Feb
ICPT Intercept $110.77 -0.42 (-0.38%) 07:22 02/19/19 02/19 07:22 02/19/19 07:22 Hot Stocks	Breaking Hot Stocks news story on Intercept » Intercept jumps 36% after… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	18 May
ICPT Intercept $110.77 -0.42 (-0.38%) 07:22 02/19/19 02/19 07:22 02/19/19 07:22 Hot Stocks	Intercept announces results from Phase 3 REGENERATE study » Intercept announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	18 May
NBLX Noble Midstream $32.09 -0.04 (-0.12%) 07:21 02/19/19 02/19 07:21 02/19/19 07:21 Earnings	Noble Midstream reports Q4 EPS $1.00, consensus $1.03 » Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Feb

FCAU Fiat Chrysler $14.75 0.09 (0.61%) 07:21 02/19/19 02/19 07:21 02/19/19 07:21 Downgrade	Fiat Chrysler rating change » Fiat Chrysler downgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
XPO XPO Logistics $52.01 -7.535 (-12.65%) , UPS UPS $110.89 -0.91 (-0.81%) … 07:20 02/19/19 02/19 07:20 02/19/19 07:20 Downgrade	XPO Logistics, UPS, FedEx, C.H. Robinson, Amazon.com rating change » Morgan Stanley downgrades… XPO XPO Logistics $52.01 -7.535 (-12.65%) UPS UPS $110.89 -0.91 (-0.81%) FDX FedEx $179.20 -4.74 (-2.58%) CHRW C.H. Robinson $91.43 0.74 (0.82%) AMZN Amazon.com $1,608.88 -13.47 (-0.83%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb 20 Feb 20 Feb 20 Feb 03 Mar 18 Mar 19 Mar 01 Apr 02 Apr
CTB Cooper Tire $34.04 0.66 (1.98%) 07:19 02/19/19 02/19 07:19 02/19/19 07:19 Hot Stocks	Cooper Tire sees modest unit volume growth compared to 2018 » Sees improving operating… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	14 Mar 14 May 15 May 16 May
CTB Cooper Tire $34.04 0.66 (1.98%) 07:18 02/19/19 02/19 07:18 02/19/19 07:18 Hot Stocks	Cooper Tire sees Q1 operating profit margin lower than Q1 » Management expects Q1… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	14 Mar 14 May 15 May 16 May
XPO XPO Logistics $52.01 -7.535 (-12.65%) 07:17 02/19/19 02/19 07:17 02/19/19 07:17 Recommendations	XPO Logistics analyst commentary » Deutsche puts… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb

OPTN Optinose $7.40 0.23 (3.21%) 07:17 02/19/19 02/19 07:17 02/19/19 07:17 Hot Stocks	Optinose announces four additional Xhance patents from USPTO » Optinose announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SXT Sensient $62.77 0.19 (0.30%) 07:15 02/19/19 02/19 07:15 02/19/19 07:15 Downgrade	Sensient rating change » Sensient downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	06 Mar
CRSP Crispr Therapeutics $31.62 0.65 (2.10%) 07:15 02/19/19 02/19 07:15 02/19/19 07:15 Hot Stocks	Crispr Therapeutics, StrideBio announce expanded strategic collaboration » Crispr Therapeutics and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
CEVA Ceva $28.91 1.23 (4.44%) 07:14 02/19/19 02/19 07:14 02/19/19 07:14 Hot Stocks	Ceva announces collaboration to add C-V2X Rel. 14/15 support to the CEVA-XC DSP » CEVA announced that the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
PLUG Plug Power $1.62 -0.045 (-2.70%) 07:14 02/19/19 02/19 07:14 02/19/19 07:14 Hot Stocks	Plug Power begins production of next gen class 1 material handling equipment » Plug Power announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

CTB Cooper Tire $34.04 0.66 (1.98%) 07:13 02/19/19 02/19 07:13 02/19/19 07:13 Earnings	Cooper Tire reports Q4 EPS ex-items 66c, consensus 58c » Reports Q4 revenue $770M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	14 Mar 14 May 15 May 16 May
ARAV Aravive $4.95 0.2 (4.21%) 07:13 02/19/19 02/19 07:13 02/19/19 07:13 Hot Stocks	Aravive receives additional $2.6M disbursement from CPRIT for AVB-S6-500 » Aravive announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
CASI Casi Pharmaceuticals $3.59 0.07 (1.99%) , SPPI Spectrum $11.71 0.03 (0.26%) 07:13 02/19/19 02/19 07:13 02/19/19 07:13 Hot Stocks	Casi Pharmaceuticals: NMPA approves CTA for trial of ZEVALIN » CASI Pharmaceuticals… CASI Casi Pharmaceuticals $3.59 0.07 (1.99%) SPPI Spectrum $11.71 0.03 (0.26%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Feb 20 Feb
PHIIK PHI Inc $3.10 0.01 (0.32%) 07:12 02/19/19 02/19 07:12 02/19/19 07:12 Hot Stocks	PHI Inc shareholder Stabosz calls on company to address Debtwire story » One of PHI, Inc.'s… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
XPO XPO Logistics $52.01 -7.535 (-12.65%) 07:12 02/19/19 02/19 07:12 02/19/19 07:12 Recommendations	XPO Logistics analyst commentary » XPO Logistics price… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb